Market Overview:
The coronary stents market is experiencing a significant
surge, driven by technological advancements, increasing prevalence of
cardiovascular diseases, and a growing aging population. According to recent
market analysis reports, the global coronary
stents market is projected to witness substantial growth in the coming
years. The market overview suggests a rising demand for minimally invasive
procedures, leading to the adoption of innovative stent technologies.
Several factors contribute to the market's growth, including
a rise in lifestyle-related diseases, such as obesity and diabetes,
contributing to an increased incidence of coronary artery diseases. Moreover,
advancements in stent design and materials, promoting better efficacy and
reduced complications, are enhancing market prospects.
Geographically, the market shows promising trends across
North America, Europe, Asia-Pacific, and other regions. The competitive
landscape is marked by key players investing in research and development to
introduce novel stents, expanding their product portfolios. Additionally,
strategic collaborations and partnerships between industry players are becoming
prevalent to leverage synergies and strengthen market presence.
Key Players
The market for global coronary
stents companies includes Terumo Corporation, Stentys SA, MicroPort
Scientific Corporation, Meril Life Sciences, Medtronic Plc, Elixir Medical
Corporation, Cook Medical, C. R. Bard, Inc., Boston Scientific Corporation,
Biotronik SE & Co. KG, B. Braun Melsungen AG, and Abbott.
Market Segmentation
The MRFR report offers an inclusive segmental analysis of
the global coronary stents market based on end users and products.
By products, the global coronary stents market is
segmented into bioresorbable vasculae scaffolds, bare metal stents, and drug
eluting stents. Of these, the drug eluting stent segment will lead the market
over the forecast period. Better patient compliance and wider acceptance in
angioplasty procedures are adding to the growth of the segment. Meanwhile, the
bioresorbable stents are predicted to grow at a fast pace over the forecast
period.
By end users, the global coronary stents market is
segmented into specialty centers, ambulatory surgical centers, hospitals and
clinics, & others. Among these, hospitals and clinics will spearhead the
market over the forecast period. Meanwhile, the ambulatory surgical centers is
predicted to grow at a fast pace over the forecast period for the growing
establishments of ambulatory surgical centers especially in developing and
developed countries.
Regional Analysis
Based on the region, the global coronary stents market
report covers the growth opportunities and recent trends across the Americas,
Europe, the Asia Pacific, & the Middle East and Africa (MEA). Among these,
the Americas will spearhead the cardiac
stents market over the forecast period. The presence of leading medical
device manufacturers, high disposable income, increasing awareness about
population, advanced treatment procedures, development of improved therapeutic
approaches, and growing cases of cardiovascular diseases like coronary artery
disease, arterial blockage, cardiac arrhythmia, among others are adding to the
global coronary stents market growth.
The global coronary stents market in Europe is predicted to
have the second-largest share over the forecast period. Growing government
support for device manufacturers and the expansion of companies geographically
are adding to the global coronary stents market growth in the region.
Over the course of the projection period, it is expected
that the global market for coronary stents in the APAC region will expand
quickly. The region's market for coronary stents is expanding as a result of
the increasing medical industry, particularly in China and India, rising
government support for healthcare, an increase in the number of medical device
firms, and rising R&D spending.
The global coronary stents market in the MEA is predicted to
have small growth over the forecast period.
Related Reports
Autism Disorder and Treatment Market
Orthopedic Biomaterials Market
No comments:
Post a Comment